PMH31 DRUG COST DEVELOPMENT OF CITALOPRAM AND FLUOXETINE FOLLOWING THE INTRODUCTION OF GENERIC SUBSTITUTION IN FINLAND
May 1, 2007, 00:00
10.1016/S1098-3015(10)68782-7
https://www.valueinhealthjournal.com/article/S1098-3015(10)68782-7/fulltext
Title :
PMH31 DRUG COST DEVELOPMENT OF CITALOPRAM AND FLUOXETINE FOLLOWING THE INTRODUCTION OF GENERIC SUBSTITUTION IN FINLAND
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)68782-7&doi=10.1016/S1098-3015(10)68782-7
First page :
Section Title :
Open access? :
No
Section Order :
568